Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis.
Hurlen, Mette
Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis. [electronic resource] - Thrombosis research 2006 - 433-8 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0049-3848
10.1016/j.thromres.2005.07.023 doi
Anticoagulants--administration & dosage
Aspirin--administration & dosage
Drug Therapy, Combination
Female
Fibrinolytic Agents--administration & dosage
Follow-Up Studies
Hematuria--chemically induced
Hemorrhage--chemically induced
Humans
Male
Middle Aged
Myocardial Infarction--drug therapy
Occult Blood
Prospective Studies
Risk Factors
Treatment Outcome
Warfarin--administration & dosage
Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis. [electronic resource] - Thrombosis research 2006 - 433-8 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0049-3848
10.1016/j.thromres.2005.07.023 doi
Anticoagulants--administration & dosage
Aspirin--administration & dosage
Drug Therapy, Combination
Female
Fibrinolytic Agents--administration & dosage
Follow-Up Studies
Hematuria--chemically induced
Hemorrhage--chemically induced
Humans
Male
Middle Aged
Myocardial Infarction--drug therapy
Occult Blood
Prospective Studies
Risk Factors
Treatment Outcome
Warfarin--administration & dosage